Nitric oxide in exhaled breath is poorly correlated to sputum eosinophils in patients with prednisone-dependent asthma
Authors:
- 1 August 2010
- journal article
- other
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 126 (2) , 404-406
Abstract
No abstract availableFunding Information
- GlaxoSmithKline
This publication has 14 references indexed in Scilit:
- Use of Exhaled Nitric Oxide Measurement to Identify a Reactive, at-Risk Phenotype among Patients with AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 2010
- Mepolizumab and Exacerbations of Refractory Eosinophilic AsthmaNew England Journal of Medicine, 2009
- Mepolizumab for Prednisone-Dependent Asthma with Sputum EosinophiliaNew England Journal of Medicine, 2009
- Airway inflammation assessed by invasive and noninvasive means in severe asthma: Eosinophilic and noneosinophilic phenotypesJournal of Allergy and Clinical Immunology, 2006
- Nitric oxide as a clinical guide for asthma managementJournal of Allergy and Clinical Immunology, 2006
- Exhaled nitric oxide identifies the persistent eosinophilic phenotype in severe refractory asthmaJournal of Allergy and Clinical Immunology, 2005
- Use of Exhaled Nitric Oxide Measurements to Guide Treatment in Chronic AsthmaNew England Journal of Medicine, 2005
- Increase in exhaled nitric oxide levels in patients with difficult asthma and correlation with symptoms and disease severity despite treatment with oral and inhaled corticosteroidsThorax, 1998
- Measurement of inflammatory indices in induced sputum: effects of selection of sputum to minimize salivary contaminationEuropean Respiratory Journal, 1996
- Inhaled Glucocorticoids Decrease Nitric Oxide in Exhaled Air of Asthmatic PatientsAmerican Journal of Respiratory and Critical Care Medicine, 1996